Ranta T, Unnérus H A, Rossi J, Seppälä M
Am J Obstet Gynecol. 1979 May 1;134(1):1-3. doi: 10.1016/0002-9378(79)90786-5.
The plasma concentrations of prolactin and estradiol-17 beta were measured by specific radioimmunoassays in 150 women with normal pregnancies and 76 women with cholestasis of pregnancy. At 33 to 34 weeks of gestation plasma prolactin concentrations were 187 +/- 23 ng/ml (mean +/- S.E.M.) for normal pregnancy and 341 +/- 38 ng/ml for cholestasis (p less than 0.001). At 35 to 36 weeks they were 254 +/- 24 and 355 +/- 26 ng/ml (p less than 0.01), and at 37 to 38 weeks 175 +/- 14 and 365 +/- 34 ng/ml (p less than 0.001), respectively. Higher prolactin levels in the cholestasis group were not related to differences in plasma estradiol-17 beta concentrations. No correlation was found between plasma prolactin and serum aminotransferase levels, or between prolactin levels and placental weight. The mechanisms by which plasma prolactin levels become elevated in cholestasis of pregnancy remain to be elucidated.
采用特异性放射免疫分析法测定了150例正常妊娠妇女和76例妊娠胆汁淤积症妇女的催乳素和雌二醇-17β的血浆浓度。妊娠33至34周时,正常妊娠组血浆催乳素浓度为187±23 ng/ml(均值±标准误),妊娠胆汁淤积症组为341±38 ng/ml(p<0.001)。妊娠35至36周时,分别为254±24和355±26 ng/ml(p<0.01),妊娠37至38周时,分别为175±14和365±34 ng/ml(p<0.001)。妊娠胆汁淤积症组较高的催乳素水平与血浆雌二醇-17β浓度的差异无关。未发现血浆催乳素与血清转氨酶水平之间、催乳素水平与胎盘重量之间存在相关性。妊娠胆汁淤积症时血浆催乳素水平升高的机制尚待阐明。